BioArctic AB Class B (BIOA.B) Stock Statistics & Valuation Metrics

BioArctic AB Class B has a market cap or net worth of kr28.89B. The enterprise value is kr25.01B.

BioArctic AB Class B has 74,324,486 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioArctic AB Class B’s return on equity (ROE) is 0.52 and return on invested capital (ROIC) is 53.81%.

The current PE Ratio of BioArctic AB Class B is 135.1. BioArctic AB Class B’s PEG ratio is -0.04.

In the last 12 months, BioArctic AB Class B had revenue of 2.00B and earned 1.02B in profits. Earnings per share was 11.55.

In the last 12 months, operating cash flow was 1.25B and capital expenditures -1.46B, giving a free cash flow of 1.25B billion.

BioArctic AB Class B pays an annual dividend of kr2, resulting in a dividend yield of ―

BioArctic AB Class B upcoming earnings date is Aug 26, 2026, Before Open (Confirmed).

BioArctic AB Class B as a current ratio of 4.78, with Debt / Equity ratio of 1.85%

In the past 12 months, BioArctic AB Class B has paid 233.26M in taxes.

BioArctic AB Class B EV to EBITDA ratio is 19.20, with an EV/FCF ratio of 18.66.

BioArctic AB Class B has kr2.03B in cash and marketable securities with kr40.74M in debt, giving a net cash position of kr1.99B billion.

Gross margin is 94.13%, with operating margin of 68.44%, and net profit margin of 51.14%.

The average price target for BioArctic AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―